APA

Chen S., Chou W. H., Blouin R. A., Mao Z., Humphries L. L., Meek Q. C., Neill J. R., Martin W. L., Hays L. R. & Wedlund P. J. (19961219). The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry. : Clinical pharmacology and therapeutics.

Chicago

Chen S, Chou W H, Blouin R A, Mao Z, Humphries L L, Meek Q C, Neill J R, Martin W L, Hays L R and Wedlund P J. 19961219. The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry. : Clinical pharmacology and therapeutics.

Harvard

Chen S., Chou W. H., Blouin R. A., Mao Z., Humphries L. L., Meek Q. C., Neill J. R., Martin W. L., Hays L. R. and Wedlund P. J. (19961219). The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry. : Clinical pharmacology and therapeutics.

MLA

Chen S, Chou W H, Blouin R A, Mao Z, Humphries L L, Meek Q C, Neill J R, Martin W L, Hays L R and Wedlund P J. The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry. : Clinical pharmacology and therapeutics. 19961219.